Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alejandro Berkovits

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Expert Review of Hematology|May 12, 2016
Double hit lymphoma: from biology to therapeutic implicationsMauricio Burotto, Alejandro Berkovits, Kieron Dunleavy
Revista Medica De Chile|December 17, 2009
[Hospital medicine]Alejandro Berkovits, Andrés Aizman, Gonzalo Eymin, et al.
Revista Medica De Chile|January 14, 2016
[Isolated factor X deficiency in chronic myelomonocytic leukemia: Report of one case]Javier Zelada, Gabriela Cantó, Alejandro Berkovits, et al.
Revista Medica De Chile|January 31, 2012
[New oral anticoagulant drugs]Alejandro Berkovits, Andrés Aizman, Pamela Zúñiga, et al.
Platelets|July 27, 2011
Clot lysis time in platelet-rich plasma: method assessment, comparison with assays in platelet-free and platelet-poor plasmas, and response to tranexamic acidOlga Panes, Oslando Padilla, Valeria Matus, et al.
Journal of Gastrointestinal Oncology|September 12, 2022
Proteogenomic analysis in an early onset diffuse gastric cancer patient revealed alterations in PIK3R1, TP53, SMAD4 and a potential role of the PI3K-AKT and EGFR pathways: a case reportMiguel Cordova-Delgado, Mauricio P Pinto, Gonzalo Pizarro, et al.
Revista Medica De Chile|August 2, 2024
[Consensus for Oncology Genetic Counseling and Molecular Diagnosis: The Punta Arenas Statement]Ricardo Fernández-Ramires, Sonia Margarit, Sebastián Morales, et al.
Journal of Personalized Medicine|February 25, 2022
Mutational Landscape and Actionable Target Rates on Advanced Stage Refractory Cancer Patients: A Multicenter Chilean ExperienceMiguel Cordova-Delgado, Mauricio P Pinto, Carlos Regonesi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 7, 2025
Pirtobrutinib Versus Ibrutinib in Treatment-Naïve and Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaJennifer A Woyach, Lugui Qiu, Sebastian Grosicki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 8, 2025
Erratum: Isatuximab Subcutaneous by On-Body Injector Versus Isatuximab Intravenous Plus Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Phase III IRAKLIA StudySikander Ailawadhi, Ivan Špička, Andrew Spencer, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Expert Review of Hematology|May 12, 2016
Double hit lymphoma: from biology to therapeutic implicationsMauricio Burotto, Alejandro Berkovits, Kieron Dunleavy
Revista Medica De Chile|December 17, 2009
[Hospital medicine]Alejandro Berkovits, Andrés Aizman, Gonzalo Eymin, et al.
Revista Medica De Chile|January 14, 2016
[Isolated factor X deficiency in chronic myelomonocytic leukemia: Report of one case]Javier Zelada, Gabriela Cantó, Alejandro Berkovits, et al.
Revista Medica De Chile|January 31, 2012
[New oral anticoagulant drugs]Alejandro Berkovits, Andrés Aizman, Pamela Zúñiga, et al.
Platelets|July 27, 2011
Clot lysis time in platelet-rich plasma: method assessment, comparison with assays in platelet-free and platelet-poor plasmas, and response to tranexamic acidOlga Panes, Oslando Padilla, Valeria Matus, et al.
Journal of Gastrointestinal Oncology|September 12, 2022
Proteogenomic analysis in an early onset diffuse gastric cancer patient revealed alterations in PIK3R1, TP53, SMAD4 and a potential role of the PI3K-AKT and EGFR pathways: a case reportMiguel Cordova-Delgado, Mauricio P Pinto, Gonzalo Pizarro, et al.
Revista Medica De Chile|August 2, 2024
[Consensus for Oncology Genetic Counseling and Molecular Diagnosis: The Punta Arenas Statement]Ricardo Fernández-Ramires, Sonia Margarit, Sebastián Morales, et al.
Journal of Personalized Medicine|February 25, 2022
Mutational Landscape and Actionable Target Rates on Advanced Stage Refractory Cancer Patients: A Multicenter Chilean ExperienceMiguel Cordova-Delgado, Mauricio P Pinto, Carlos Regonesi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 7, 2025
Pirtobrutinib Versus Ibrutinib in Treatment-Naïve and Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaJennifer A Woyach, Lugui Qiu, Sebastian Grosicki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 8, 2025
Erratum: Isatuximab Subcutaneous by On-Body Injector Versus Isatuximab Intravenous Plus Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Phase III IRAKLIA StudySikander Ailawadhi, Ivan Špička, Andrew Spencer, et al.
Pageof 2